James Dentzer
Chief Executive Officer bij CURIS, INC.
Vermogen: 55 963 $ op 29-02-2024
Profiel
Presently, James E.
Dentzer occupies the position of President, Chief Executive Officer & Director at Curis, Inc. He is also on the board of Imunon, Inc.
He previously held the position of Chief Financial Officer of Amicus Therapeutics, Inc., Controller of Biogen, Inc., Chief Financial Officer for Dicerna Pharmaceuticals, Inc., Chief Financial Officer at Valeritas, Inc. and Chief Financial Officer-DuPont Flooring Systems at EIDP, Inc.
James E.
Dentzer received an undergraduate degree from Boston College and an MBA from The University of Chicago Booth School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CURIS, INC.
0.09% | 31-07-2023 | 5 492 ( 0.09% ) | 55 963 $ | 29-02-2024 |
IMUNON, INC.
-.--% | 15-03-2024 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van James Dentzer
Bedrijven | Functie | Begin |
---|---|---|
CURIS, INC. | Chief Executive Officer | 24-09-2018 |
IMUNON, INC. | Director/Board Member | 03-10-2022 |
Eerdere bekende functies van James Dentzer
Bedrijven | Functie | Einde |
---|---|---|
DICERNA PHARMACEUTICALS, INC. | Director of Finance/CFO | 15-12-2015 |
VALERITAS INC | Director of Finance/CFO | 01-12-2013 |
AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 29-10-2009 |
BIOGEN INC. | Comptroller/Controller/Auditor | - |
E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Opleiding van James Dentzer
Boston College | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
BIOGEN INC. | Health Technology |
IMUNON, INC. | Health Technology |
CURIS, INC. | Health Technology |
AMICUS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. Its activities include electronics and communications, protection solutions, nutrition and health, transportation and polymers, packaging and specialty plastics, and industrial biosciences. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Valeritas, Inc.
Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |